It has been too long, so here are a few of my favorite recent pieces from the world of biotech, pharmaceuticals, and drug development:
Precision Oncology Isn’t Quite There Yet
Derek Lowe (In the Pipeline)
Beyond Biotech M&A: What Comes Thereafter
Samantha Truex (LifeSciVC)
What's So Significant About Significance?
Shane Parrish (Farnam Street)
The World’s Most Expensive Medicine Is a Bust
Antonio Regalado (MIT Technology Review)
Did A Biotech CEO Reverse Her Own Aging Process? Probably Not
Steven Salzberg (Forbes)
When you’re the scientist in the family
Adam Ruben (Science)
Better, Faster, More Comprehensive Manure Distribution
Derek Lowe (In the Pipeline)
Precision Oncology Isn’t Quite There Yet
Derek Lowe (In the Pipeline)
Beyond Biotech M&A: What Comes Thereafter
Samantha Truex (LifeSciVC)
What's So Significant About Significance?
Shane Parrish (Farnam Street)
The World’s Most Expensive Medicine Is a Bust
Antonio Regalado (MIT Technology Review)
Did A Biotech CEO Reverse Her Own Aging Process? Probably Not
Steven Salzberg (Forbes)
When you’re the scientist in the family
Adam Ruben (Science)
Better, Faster, More Comprehensive Manure Distribution
Derek Lowe (In the Pipeline)
RSS Feed
